Inhibition of hepsin in human breast cancer explants

Human breast tumor explants were treated with the hepsin inhibitory antibody Ab25 (5µM, 48h). Overall design: The raw data files in this submission are not de-multiplexed. All sample metadata are included in the EGFR_sample_information.xlsx file linked to the foot of this record.